Evidence map›Paper›PMID 37881714›Full record

ArticleNanoscale advances2023

Dual-color core-shell silica nanosystems for advanced super-resolution biomedical imaging.

Maria Antonieta Ramirez-Morales, Elisa De Luca, Chiara Coricciati, Alberto Rainer, Giuseppe Gigli, Giuseppe Mele, Pier Paolo Pompa, Maria Ada Malvindi

Abstract read
In one paragraph

Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nanoengineered Silica-Based Biomaterials for Regenerative Medicine.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria Antonieta Ramirez-MoralesHiQ-Nano s.r.l. Via Barsanti 1, Arnesano Lecce 73010 Italy maryarmzm@gmail.com mariada.malvindi@hiqnano.com.ORCID https://orcid.org/0000-0003-1708-7299
Elisa De LucaInstitute of Nanotechnology (NANOTEC)-National Research Council (CNR) Lecce 73100 Italy.ORCID https://orcid.org/0000-0001-9849-0703
Chiara CoricciatiInstitute of Nanotechnology (NANOTEC)-National Research Council (CNR) Lecce 73100 Italy.ORCID https://orcid.org/0009-0003-6718-4924
Alberto RainerInstitute of Nanotechnology (NANOTEC)-National Research Council (CNR) Lecce 73100 Italy.ORCID https://orcid.org/0000-0001-8971-551X
Giuseppe GigliInstitute of Nanotechnology (NANOTEC)-National Research Council (CNR) Lecce 73100 Italy.ORCID https://orcid.org/0000-0002-2583-5747
Giuseppe MeleDepartment of Engineering of Innovation, Università del Salento Via Monteroni Lecce 73100 Italy.ORCID https://orcid.org/0000-0002-6684-990X
Pier Paolo PompaNanobiointeractions & Nanodiagnostics, Istituto Italiano di Tecnologia (IIT) Via Morego 30 Genova 16163 Italy.ORCID https://orcid.org/0000-0001-7549-0612
Maria Ada MalvindiHiQ-Nano s.r.l. Via Barsanti 1, Arnesano Lecce 73010 Italy maryarmzm@gmail.com mariada.malvindi@hiqnano.com.ORCID https://orcid.org/0009-0005-6730-7474

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescent core-shell silica nanoparticles are largely employed in nanomedicine and life science thanks to the many advantages they offer. Among these, the enhancement of the stability of the fluorescent signal upon fluorophore encapsulation into the silica matrix and the possibility to combine in a single vehicle multiple functionalities, physically separated in different compartments. In this work, we present a new approach to the Stöber method as a two-cycle protocol for the tailored synthesis of dual-color fluorescent core-shell silicon dioxide nanoparticles (SiO

Identifiers

PMID37881714
PMCPMC10597559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.